期刊文献+

proEMAPⅡ/p43蛋白对干扰素诱导蛋白10的调控

Regulation of pro EMAPⅡ/p43 on the Interferon Inducible Protein 10
下载PDF
导出
摘要 目的:研究p43蛋白对干扰素诱导蛋白10(IP10)的调控。方法:用实时定量PCR方法检测p43蛋白作用于HMEC-1细胞后IP10基因水平的变化,并找到p43蛋白作用的最佳浓度范围及最佳作用时间;同时用ELISA方法检测p43蛋白是否促进IP10蛋白的分泌,并检测p43蛋白对可能引起IP10上调的相关因子γ干扰素(IFNγ)、白细胞介素1β(IL1β)及肿瘤坏死因子α(TNFα)的调控作用,试图找到p43蛋白诱导IP10表达上调的原因。结果及结论:p43蛋白能显著上调IP10的表达,并具有一定的量效关系,在p43浓度为70μg/m L、作用时间为6 h时达到峰值;p43蛋白能够诱导IFNγ的分泌,p43蛋白诱导IP10的表达可能是通过上调IFNγ的分泌,并经由JAK-STAT途径实现的。 Objective: To study the regulation of p43 protein on the interferon inducible protein 10(IP10). Methods: With the method of real-time quantitative PCR to detect the IP10 gene level changes of p43 pro?tein on HMEC-1 cells, and find the best role of p43 protein concentration range, and the best reaction time; and detect the IP10 protein secretion measured by ELISA. p43 protein may lead to increase of the relevant fac?tors IFNγ, IL1β and TNFα, so we detect whether the p43 protein could increse those factors. Trying to find the regulation of p43 protein on IP10. Results & Conclusion: p43 protein can significantly increase the expression of IP10, and with a certain dose-effect relationship. The optimal concentration of p43 was 70 μg/ml, and when role 6 h the IP10 have a significant secretion. While p43 protein can induce the secretion of IFNγ protein. IP10-induced expression may be through increased IFNγ protein secretion, and achieve through the way of JAK-STAT.
出处 《生物技术通讯》 CAS 2014年第6期779-782,共4页 Letters in Biotechnology
关键词 p43蛋白 干扰素诱导蛋白10 Γ干扰素 p43 protein interferon inducible protein 10 IFNγ
  • 相关文献

参考文献6

  • 1Quevilhm S. Ag, m F. Robinson J C. et al. The p43 compo- nent of the mammalian multi-synlhetase complex is likely to be the preeursor of the endothelial monocyte-activating poly peptidell cytokine[j]. Biol Chem, 1997,272(51):32573-32579. 被引量:1
  • 2Han J M, Kim J Y, Kim S. Molecular network anti functional implications of macromoleeular tRNA synthetasc complex[J]. Biochem Biophys Res Commun, 2003,303(4-):985-993. 被引量:1
  • 3Park S G. Jung K H, Lee J S, et al. Precursor of pro-apop- totie cytokine modulates aminoacylation activity of IRNA syn-thetase[J]. Biol Chem, 1999,274(24):16673-16676. 被引量:1
  • 4邢玉华,刘大涛,刘刚,邹亮,胡立德,付学奇,陈惠鹏.重组人proEMAPⅡ/p43体外抑制新生血管生成活性方法的建立[J].军事医学科学院院刊,2010,34(4):317-320. 被引量:2
  • 5Neville L F, Mathiak G, Bagasra O. The immune biology of interferon-gamma inducible protein lOkD(IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily[J]. Cytokine Growth Factor Rev, 1997,8(3):207-219. 被引量:1
  • 6Darnell J E Jr, Kerr I M, Stark G R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins[J]. Science, 1994,264(5164): 1415-1424. 被引量:1

二级参考文献15

  • 1Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases[J].Nature,2000,407(6801):249-257. 被引量:1
  • 2Folkman J.Tumor angiogenesis:therapeutic implication[J].New Engl J Med,1971,285(21):1182-1186. 被引量:1
  • 3Liekens S,De Clereq E,Neyts J.Angiogenesis:regulators and clinical applications[J].Biochem Pharmacol,2001,61(3):253-270. 被引量:1
  • 4Tandle A,Blazer DG 3rd,Libutti SK.Antiangiogenic gene therapy of cancer:recent developments[J].J Transl Med,2004,2(1):22-42. 被引量:1
  • 5Ko YG,Park H,Kim T,et al.A cofactor of tRNA synthetase,p43,is secreted to up-regulate proinflammatory genes[J].J Biol Chem,2001,276(25):23028-23033. 被引量:1
  • 6Shalak V,Kaminska M,Mitnacht-Kraus R,et al.The EMAPⅡ cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPⅡ component[J].J Biol Chem,2001,276(26):23769-23776. 被引量:1
  • 7Staton CA,Stribbling SM,Tazzyman S,et al.Current methods for assaying angiogenesis in vitro and in vivo[J].Int J Exp Path,2004,85(5):233-248. 被引量:1
  • 8Auerbach R,Lewis R,Shinners B,et al.Angiogenesis assays:a critical overview[J].Clin Chem,2003,49(1):32-40. 被引量:1
  • 9Hlatky L,Hahnfeldt P,Folkman J.Clinical application of antiangiogenic therapy:microvessel density,what it does and doesn′t tell us[J].J Natl Cancer Inst,2002,94(12):883-893. 被引量:1
  • 10Ziche M,Donnini S,Morbidelli L.Development of new drugs in angiogenesis[J].Curr Drug Targets,2004,5(5):485-493. 被引量:1

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部